Ondansetron own mechanism of action as a serotonin inhibitor seems to be the one responsible for these behavioral changes in alcohol consumption. Alcohol craving is in fact believed to be caused by an imbalance between the two neurotransmitters dopamine and serotonin. Zofran blocks the serotonin recept...
Food and Drug Administration has granted conditional approval to Vivitrol, a once-a-month, naltrexone-based drug intended to curb craving for alcohol, Reuters reported Dec. 29. -- The injectable drug, developed by Alkermes, Inc., is expected to hit the market in 2006. The company still has...